FormFactor, Inc. 10-Q Summary
Business Context and Reporting Period
FormFactor provides semiconductor test and measurement technologies, including probe cards, probe stations, metrology, thermal, and cryogenic systems. The company operates through Probe Cards and Systems segments. This unaudited report covers the 13 weeks ended March 26, 2022, compared with the 13 weeks ended March 27, 2021.
Key Financial Metrics
| Metric | Q1 2022 | Q1 2021 | Change |
|---|---|---|---|
| Revenue | $197.2 million | $186.6 million | Up 5.6% |
| Gross profit | $94.2 million | $76.7 million | Up 22.8% |
| Gross margin | 47.8% | 41.1% | Up 6.7 percentage points |
| Operating income | $34.2 million | $22.6 million | Up 51.0% |
| Operating margin | 17.3% | 12.1% | Up 5.2 percentage points |
| Net income | $29.9 million | $19.6 million | Up 52.2% |
| Diluted EPS | $0.38 | $0.25 | Up $0.13 |
| Effective tax rate | 13.0% | 14.0% | Down 1.0 percentage point |
| Operating cash flow | $44.2 million | $32.4 million | Up $11.8 million |
Probe Cards revenue was $160.0 million, up 0.7%, while Systems revenue was $37.2 million, up 34.1%. Systems growth reflected higher sales of metrology systems and 200- and 300-millimeter probe stations. Gross margins were 48.3% for Probe Cards and 52.2% for Systems.
At March 26, 2022, cash and cash equivalents were $167.2 million, marketable securities were $129.2 million, and total cash, cash equivalents, and marketable securities were approximately $296.4 million. Working capital was $401.5 million. Total debt was approximately $22.0 million, consisting primarily of the FRT Term Loan and Building Term Loan.
Net cash used in investing was $21.1 million, including $15.6 million of capital expenditures and $5.5 million of net purchases of marketable securities. Net cash used in financing was $6.0 million, including $9.4 million of share repurchases and $2.2 million of term-loan principal repayments. Cash, cash equivalents, and restricted cash increased by $15.9 million to $171.3 million.
Material Changes Versus the Prior Comparable Period
- Revenue increased $10.5 million, driven primarily by a $9.5 million increase in Systems revenue.
- Gross profit and gross margin improved due to favorable product mix, higher production volumes and factory absorption, lower amortization of intangible assets, and improved Systems fixed-cost leverage. Higher material costs partially offset the benefit.
- Research and development expense increased 12.8% to $27.1 million, primarily due to higher headcount, compensation, operating costs, project materials, and stock-based compensation.
- Selling, general and administrative expense increased 9.6% to $32.9 million, reflecting higher headcount, salary adjustments, travel as COVID-19 restrictions eased, and stock-based compensation.
- Amortization expense declined to $2.4 million from $6.8 million because significant acquired intangible assets became fully amortized.
- Inventory increased to $125.6 million from $111.5 million at December 25, 2021, while accounts payable increased to $65.4 million from $57.9 million.
- The company repurchased 240,548 shares for $9.4 million during the quarter. Approximately $16.6 million remained available under the repurchase authorization, which expires October 28, 2022.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
The filing does not provide a specific numerical revenue or earnings forecast. Management expects available cash, marketable securities, and operating cash generation to fund expected short- and long-term operating requirements, including capital expenditures, research and development, working capital, and existing commitments. Future acquisitions or strategic investments could require additional financing.
COVID-19 continued to affect supply chains and could cause manufacturing, design, customer-support, productivity, or demand disruptions. Other principal risks include semiconductor industry cyclicality, supply constraints and reliance on certain sole-source suppliers, customer concentration, export controls and trade barriers, geopolitical developments including the Russia-Ukraine conflict, foreign-exchange and interest-rate exposure, and changes in tax rules.
Intel represented 20.8% of revenue and Taiwan Semiconductor Manufacturing Co. represented 10.7% in Q1 2022; together they represented 31.5% of revenue. One customer represented 22.8% of gross accounts receivable at March 26, 2022.
Restructuring plans to consolidate or relocate facilities are expected to generate aggregate charges of approximately $6.0 million to $9.0 million, with most actions expected to be completed by December 2022. The company had recognized $4.4 million through the filing date and recorded $313,000 of restructuring charges during the quarter. The remaining restructuring accrual was $890,000 at March 26, 2022.
Remaining performance obligations were $7.7 million, of which approximately 75.6% is expected to be recognized during the remainder of fiscal 2022. The company reported no material legal proceedings, no material changes to previously disclosed risk factors, and no material changes in contractual obligations.
Important Facts for Investors to Verify
- Whether Systems revenue growth and elevated gross margins are sustained in subsequent quarters.
- Inventory growth, supply-chain constraints, material costs, and potential inventory impairments.
- Customer concentration and changes in demand from Intel, TSMC, and other major semiconductor customers.
- Actual costs and completion timing of the $6.0 million to $9.0 million restructuring program.
- Capital expenditure requirements and the effect of the semiconductor cycle, COVID-19, trade restrictions, and geopolitical events.
- Repurchase activity and the remaining authorization before its October 2022 expiration.
- Debt repayment requirements, including the expected payoff of the $5.8 million FRT Term Loan by October 25, 2022.
- The effect of tax-law changes requiring capitalization and amortization of research and experimental expenditures beginning in 2022.